Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.39

-1.9%

Nov 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2901)	7/1/2010 3:53:47 PM
From: Jibacoa	Read Replies (1) of 3722

AVNR is trading near its intraday H,it was up 14% and is still up 12.45% on volume of > 6M >2x its ADV bigcharts.marketwatch.com An annalyst at Jeffries recommended the stock with a "buy" rating, saying that is likely that the FDA will approve the NDA for Zenvia. The FDA is expected to make a decision on the drug in October.<g> The stock has resistance fro its June 10 H of $2.90 before it can test the more important above the $3 level. The ACTAY is $7.98 I will still keep a TT at $4 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next